[{
		"activities" : [{
				"activity_acronym" : "DM2Y",
				"activity_id" : 1,
				"activity_name" : "Drugs on the Market for >2 years",
				"subactivities" : [{
						"subactivity_acronym" : "ANGIO",
						"subactivity_id" : 1,
						"subactivity_name" : "Angiodema"
					}, {
						"subactivity_acronym" : "ASE",
						"subactivity_id" : 2,
						"subactivity_name" : "Asenapine-Aripiprazole"
					}, {
						"subactivity_acronym" : "ST",
						"subactivity_id" : 3,
						"subactivity_name" : "Stalevo"
					}
				]
			}, {
				"activity_acronym" : "DRG",
				"activity_id" : 2,
				"activity_name" : "Drug Use Studies - Comparison to Nationally Projected Databases",
				"subactivities" : [{
						"subactivity_acronym" : "USE",
						"subactivity_id" : 4,
						"subactivity_name" : "Drug Use"
					}
				]
			}, {
				"activity_acronym" : "NME",
				"activity_id" : 3,
				"activity_name" : "New Molecular Entities (NMEs)",
				"subactivities" : [{
						"subactivity_acronym" : "DABI",
						"subactivity_id" : 5,
						"subactivity_name" : "Dabigatran"
					}, {
						"subactivity_acronym" : "SAX",
						"subactivity_id" : 6,
						"subactivity_name" : "Saxagliptan"
					}
				]
			}, {
				"activity_acronym" : "REGACT",
				"activity_id" : 4,
				"activity_name" : "Evaluation of Effects of FDA's Regulatory Actions",
				"subactivities" : [{
						"subactivity_acronym" : "LABA",
						"subactivity_id" : 7,
						"subactivity_name" : "LABA"
					}
				]
			}
		],
		"id" : "03"
	}, {
		"activities" : [{
				"activity_acronym" : "HOI",
				"activity_id" : 5,
				"activity_name" : "HOI Validation/Adjudication",
				"subactivities" : [{
						"subactivity_acronym" : "ANPX",
						"subactivity_id" : 8,
						"subactivity_name" : "Anaphylaxis"
					}, {
						"subactivity_acronym" : "SALI",
						"subactivity_id" : 9,
						"subactivity_name" : "Severe Liver Injury"
					}
				]
			}, {
				"activity_acronym" : "LINK",
				"activity_id" : 6,
				"activity_name" : "Linking of Distributed Database Environments",
				"subactivities" : [{
						"subactivity_acronym" : "ANON",
						"subactivity_id" : 10,
						"subactivity_name" : "Anonymous Linking"
					}
				]
			}, {
				"activity_acronym" : "METH",
				"activity_id" : 7,
				"activity_name" : "Statistical Methods Development",
				"subactivities" : [{
						"subactivity_acronym" : "DIST",
						"subactivity_id" : 11,
						"subactivity_name" : "Evaluating Strategies for Data Sharing and Analyses in Distributed Data Settings"
					}, {
						"subactivity_acronym" : "FDA",
						"subactivity_id" : 12,
						"subactivity_name" : "Methods to Evaluate Impact of FDA Regulatory Actions"
					}, {
						"subactivity_acronym" : "SIGN",
						"subactivity_id" : 13,
						"subactivity_name" : "Framework for Assessment of Signal Refinement Positive Results"
					}, {
						"subactivity_acronym" : "TAX",
						"subactivity_id" : 14,
						"subactivity_name" : "Taxonomy"
					}
				]
			}
		],
		"id" : "04"
	}, {
		"activities" : [{
				"activity_acronym" : "BCMAT",
				"activity_id" : 8,
				"activity_name" : "Linkage with additional data source",
				"subactivities" : []
			}, {
				"activity_acronym" : "PCV13",
				"activity_id" : 9,
				"activity_name" : "General vaccine safety surveillance",
				"subactivities" : []
			}, {
				"activity_acronym" : "SAB",
				"activity_id" : 10,
				"activity_name" : "Influenza vaccine and spontaneous abortion",
				"subactivities" : []
			}
		],
		"id" : "05"
	}, {
		"activities" : [{
				"activity_acronym" : "ASSESS",
				"activity_id" : 11,
				"activity_name" : "Conduct an evaluation for thromboembolic events (TEE) after immunoglobulin administration, and assess the positive predictive value of the detection algorithm",
				"subactivities" : [{
						"subactivity_acronym" : "IVIG",
						"subactivity_id" : 18,
						"subactivity_name" : "IVIG"
					}, {
						"subactivity_acronym" : "TBD1",
						"subactivity_id" : 19,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD2",
						"subactivity_id" : 20,
						"subactivity_name" : "TBD"
					}
				]
			}, {
				"activity_acronym" : "BUILDDD",
				"activity_id" : 13,
				"activity_name" : "Define the surveillance population and create the distributed database",
				"subactivities" : [{
						"subactivity_acronym" : "PHASE1",
						"subactivity_id" : 21,
						"subactivity_name" : "Phase 1"
					}, {
						"subactivity_acronym" : "PHASE2",
						"subactivity_id" : 22,
						"subactivity_name" : "Phase 2"
					}, {
						"subactivity_acronym" : "PHASE3",
						"subactivity_id" : 23,
						"subactivity_name" : "Phase 3"
					}
				]
			}, {
				"activity_acronym" : "CHARACT",
				"activity_id" : 14,
				"activity_name" : "Characterize the Blood-SCAN distributed database",
				"subactivities" : [{
						"subactivity_acronym" : "CHARACT",
						"subactivity_id" : 24,
						"subactivity_name" : "Exposures"
					}
				]
			}
		],
		"id" : "06"
	}, {
		"activities" : [{
				"activity_acronym" : "ADD",
				"activity_id" : 15,
				"activity_name" : "Add on",
				"subactivities" : [{
						"subactivity_acronym" : "MCM",
						"subactivity_id" : 27,
						"subactivity_name" : "MCM exercise/pilot"
					}, {
						"subactivity_acronym" : "NDI",
						"subactivity_id" : 28,
						"subactivity_name" : "NDI Linkage"
					}, {
						"subactivity_acronym" : "PREG",
						"subactivity_id" : 29,
						"subactivity_name" : "Pregnancy"
					}, {
						"subactivity_acronym" : "DOXY",
						"subactivity_id" : 26,
						"subactivity_name" : "Doxycycline and cipro"
					}, {
						"subactivity_acronym" : "AS",
						"subactivity_id" : 25,
						"subactivity_name" : "Analytic Support for One-Time Assessments"
					}
				]
			}, {
				"activity_acronym" : "DM2Y",
				"activity_id" : 16,
				"activity_name" : "Drugs on the Market for >2 years",
				"subactivities" : [{
						"subactivity_acronym" : "SALIFG",
						"subactivity_id" : 35,
						"subactivity_name" : "Antifungals and Severe Liver Injury-terminated post-feasibility assessment per FDA"
					}, {
						"subactivity_acronym" : "APY1",
						"subactivity_id" : 30,
						"subactivity_name" : "Antipsychotics-Youths Subproject 1"
					}, {
						"subactivity_acronym" : "APY2a",
						"subactivity_id" : 31,
						"subactivity_name" : "Antipsychotics-Youths Subproject 2a"
					}, {
						"subactivity_acronym" : "APY2b",
						"subactivity_id" : 32,
						"subactivity_name" : "Antipsychotics-Youths Subproject 2b"
					}, {
						"subactivity_acronym" : "APY3",
						"subactivity_id" : 33,
						"subactivity_name" : "Antipsychotics-Youths Subproject 3"
					}, {
						"subactivity_acronym" : "IVIRON",
						"subactivity_id" : 34,
						"subactivity_name" : "Parenteral Iron and Anaphylaxis"
					}
				]
			}, {
				"activity_acronym" : "DRG",
				"activity_id" : 17,
				"activity_name" : "Drug Use Studies - Comparison to Nationally Projected Databases",
				"subactivities" : [{
						"subactivity_acronym" : "No Subactivity",
						"subactivity_id" : 100012,
						"subactivity_name" : "No Subactivity"
					}
				]
			}, {
				"activity_acronym" : "NME",
				"activity_id" : 18,
				"activity_name" : "New Molecular Entities (NMEs)",
				"subactivities" : [{
						"subactivity_acronym" : "TBD",
						"subactivity_id" : 41,
						"subactivity_name" : ""
					}, {
						"subactivity_acronym" : "TBD1",
						"subactivity_id" : 42,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD2",
						"subactivity_id" : 43,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "SAXHF",
						"subactivity_id" : 40,
						"subactivity_name" : "Heart Failure"
					}, {
						"subactivity_acronym" : "SAX",
						"subactivity_id" : 39,
						"subactivity_name" : "Saxagliptan-Sitagliptan AMI"
					}, {
						"subactivity_acronym" : "DABI",
						"subactivity_id" : 38,
						"subactivity_name" : "Dabigatran"
					}, {
						"subactivity_acronym" : "ASE",
						"subactivity_id" : 37,
						"subactivity_name" : "Asenapine-Aripiprazole"
					}
				]
			}, {
				"activity_acronym" : "REGACT",
				"activity_id" : 19,
				"activity_name" : "Evaluation of Effects of FDA's Regulatory Actions",
				"subactivities" : [{
						"subactivity_acronym" : "TBD2",
						"subactivity_id" : 45,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD1",
						"subactivity_id" : 44,
						"subactivity_name" : "TBD"
					}
				]
			}
		],
		"id" : "07"
	}, {
		"activities" : [{
				"activity_acronym" : "ALG",
				"activity_id" : 20,
				"activity_name" : "Surveillance Preparedness",
				"subactivities" : [{
						"subactivity_acronym" : "HOI",
						"subactivity_id" : 47,
						"subactivity_name" : "15 HOIs"
					}, {
						"subactivity_acronym" : "COHRT",
						"subactivity_id" : 46,
						"subactivity_name" : "15 Cohorts"
					}
				]
			}, {
				"activity_acronym" : "HOI",
				"activity_id" : 21,
				"activity_name" : "Alternative Approaches for HOI Validation",
				"subactivities" : [{
						"subactivity_acronym" : "ALT",
						"subactivity_id" : 50,
						"subactivity_name" : "Alternative Approaches"
					}, {
						"subactivity_acronym" : "AFIB",
						"subactivity_id" : 48,
						"subactivity_name" : "Atrial Fibrillation"
					}, {
						"subactivity_acronym" : "AKI",
						"subactivity_id" : 49,
						"subactivity_name" : "Acute Kidney Injury"
					}, {
						"subactivity_acronym" : "ANEMIA",
						"subactivity_id" : 51,
						"subactivity_name" : "Hemolytic Anemia"
					}, {
						"subactivity_acronym" : "TE",
						"subactivity_id" : 52,
						"subactivity_name" : "Thromboembolism"
					}
				]
			}, {
				"activity_acronym" : "METH",
				"activity_id" : 23,
				"activity_name" : "Extension of Methods Taxonomy",
				"subactivities" : [{
						"subactivity_acronym" : "TAX",
						"subactivity_id" : 61,
						"subactivity_name" : "Taxonomy"
					}, {
						"subactivity_acronym" : "P2HDPS",
						"subactivity_id" : 56,
						"subactivity_name" : "PROMPT 2/HDPS"
					}, {
						"subactivity_acronym" : "P1SCD",
						"subactivity_id" : 54,
						"subactivity_name" : "PROMPT 1/Self-ControlDesign"
					}, {
						"subactivity_acronym" : "P34ENHAN",
						"subactivity_id" : 57,
						"subactivity_name" : "PROMPT 3/Regression 4/ITPW Enhancements"
					}, {
						"subactivity_acronym" : "P2ENHAN",
						"subactivity_id" : 55,
						"subactivity_name" : "PROMPT 2/PSM Enchancements"
					}, {
						"subactivity_acronym" : "CONFOUND",
						"subactivity_id" : 53,
						"subactivity_name" : "Confounder Adjustment"
					}, {
						"subactivity_acronym" : "P3SEQMETH",
						"subactivity_id" : 58,
						"subactivity_name" : "PROMPT 3/Sequential Methods"
					}, {
						"subactivity_acronym" : "ROBUST",
						"subactivity_id" : 59,
						"subactivity_name" : "Robustness of drug safety monitoring results"
					}, {
						"subactivity_acronym" : "SUPP",
						"subactivity_id" : 60,
						"subactivity_name" : "Supplemental Info"
					}
				]
			}
		],
		"id" : "08"
	}, {
		"activities" : [{
				"activity_acronym" : "ADD",
				"activity_id" : 27,
				"activity_name" : "Add on",
				"subactivities" : [{
						"subactivity_acronym" : "NDI",
						"subactivity_id" : 62,
						"subactivity_name" : "NDI Linkage - Investigators"
					}
				]
			}, {
				"activity_acronym" : "DENOVO",
				"activity_id" : 28,
				"activity_name" : "Development of Modular Programs Modified with  De Novo Programming to Address CDER Drug Safety Issues",
				"subactivities" : [{
						"subactivity_acronym" : "FREQ",
						"subactivity_id" : 64,
						"subactivity_name" : "Frequency Module"
					}, {
						"subactivity_acronym" : "DOSING",
						"subactivity_id" : 63,
						"subactivity_name" : "Daily Dosing Module"
					}, {
						"subactivity_acronym" : "PDX",
						"subactivity_id" : 65,
						"subactivity_name" : "Encounter Type - Primary Diagnosis Flag Module"
					}
				]
			}, {
				"activity_acronym" : "EXPERT",
				"activity_id" : 29,
				"activity_name" : "Provision of Expert Input on Issues of Data Availability, Access and Enhancement and on Issues Related to Data Use for Specific Drug Safety Issues",
				"subactivities" : [{
						"subactivity_acronym" : "TBD5",
						"subactivity_id" : 70,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD1",
						"subactivity_id" : 66,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD3",
						"subactivity_id" : 68,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD4",
						"subactivity_id" : 69,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD2",
						"subactivity_id" : 67,
						"subactivity_name" : "TBD"
					}
				]
			}, {
				"activity_acronym" : "LITSRCH",
				"activity_id" : 30,
				"activity_name" : "Preparation of Systematic Literature Searches, Epidemiologic Assessment of Literature, and Associated Background Materials for Potential Protocol Based Assessments",
				"subactivities" : [{
						"subactivity_acronym" : "TBD4",
						"subactivity_id" : 73,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD5",
						"subactivity_id" : 74,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD2",
						"subactivity_id" : 71,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD3",
						"subactivity_id" : 72,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD1",
						"subactivity_id" : 118,
						"subactivity_name" : "TBD"
					}
				]
			}, {
				"activity_acronym" : "MEDREC",
				"activity_id" : 31,
				"activity_name" : "Medical Record Review in Conjunction with Either Protocol Based Assessments or with Modified Modular Programs",
				"subactivities" : [{
						"subactivity_acronym" : "TBD2",
						"subactivity_id" : 76,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD3",
						"subactivity_id" : 77,
						"subactivity_name" : "TBD"
					}, {
						"subactivity_acronym" : "TBD1",
						"subactivity_id" : 75,
						"subactivity_name" : "TBD"
					}
				]
			}
		],
		"id" : "10"
	}, {
		"activities" : [{
				"activity_acronym" : "ASSESS",
				"activity_id" : 32,
				"activity_name" : "Evaluating Blood-SCAN Findings through Chart Review",
				"subactivities" : [{
						"subactivity_acronym" : "TRALI",
						"subactivity_id" : 79,
						"subactivity_name" : ""
					}, {
						"subactivity_acronym" : "IVIG",
						"subactivity_id" : 78,
						"subactivity_name" : "Thromboembolic"
					}
				]
			}
		],
		"id" : "11"
	}, {
		"activities" : [{
				"activity_acronym" : "CAP",
				"activity_id" : 35,
				"activity_name" : "Create Capacity for Implementation of Routine Surveillance and Expand Capacity Modular Program and Summary Table Queries",
				"subactivities" : [{
						"subactivity_acronym" : "No Subactivity",
						"subactivity_id" : 100010,
						"subactivity_name" : "No Subactivity"
					}
				]
			}, {
				"activity_acronym" : "EFFIC",
				"activity_id" : 33,
				"activity_name" : "Implementing Efficiencies to Improve the Query Fulfillment Process",
				"subactivities" : []
			}, {
				"activity_acronym" : "METH",
				"activity_id" : 34,
				"activity_name" : "Methods Development",
				"subactivities" : [{
						"subactivity_acronym" : "pepr",
						"subactivity_id" : 84,
						"subactivity_name" : "Roadmap for creation of a generalized Mini-Sentinel patient episode profile retrieval tool"
					}, {
						"subactivity_acronym" : "sop",
						"subactivity_id" : 86,
						"subactivity_name" : "SOP for signal follow-up"
					}, {
						"subactivity_acronym" : "SUPDM",
						"subactivity_id" : 87,
						"subactivity_name" : "SUPREME DM Registry Linking to MSDD"
					}, {
						"subactivity_acronym" : "LAB",
						"subactivity_id" : 82,
						"subactivity_name" : "Analyzing Lab Data"
					}, {
						"subactivity_acronym" : "hiscom",
						"subactivity_id" : 81,
						"subactivity_name" : "Current v historical  comparisons in MSDD"
					}, {
						"subactivity_acronym" : "plink",
						"subactivity_id" : 85,
						"subactivity_name" : "PCORnet linking"
					}, {
						"subactivity_acronym" : "opi",
						"subactivity_id" : 83,
						"subactivity_name" : "Opioid prescribing"
					}
				]
			}, {
				"activity_acronym" : "PROMPT",
				"activity_id" : 36,
				"activity_name" : "Create Capacity for Implementation of Routine Surveillance and Expand Capacity Modular Program and Summary Table Queries [PROMPT]",
				"subactivities" : [{
						"subactivity_acronym" : "RIVA",
						"subactivity_id" : 90,
						"subactivity_name" : "Routine Surveillance-Rivaroxaban"
					}, {
						"subactivity_acronym" : "MIRA",
						"subactivity_id" : 89,
						"subactivity_name" : "Routine Surveillance-Mirabegron"
					}
				]
			}, {
				"activity_acronym" : "RNDM",
				"activity_id" : 37,
				"activity_name" : "Developing Approaches for Randomization within MSDD",
				"subactivities" : []
			}, {
				"activity_acronym" : "RS",
				"activity_id" : 38,
				"activity_name" : "Expansion of Routine Surveillance Capabilities",
				"subactivities" : [{
						"subactivity_acronym" : "TESTPROMPT",
						"subactivity_id" : 96,
						"subactivity_name" : "Test the active surveillance modules"
					}, {
						"subactivity_acronym" : "PRIORITY",
						"subactivity_id" : 95,
						"subactivity_name" : "Identify high priority HOI, cohort, and confounders"
					}, {
						"subactivity_acronym" : "DEVALG",
						"subactivity_id" : 93,
						"subactivity_name" : "Develop an approach for incorporation of algorithms into existing modular programs"
					}, {
						"subactivity_acronym" : "INCORPALG",
						"subactivity_id" : 94,
						"subactivity_name" : "Incorporating algorithms into active surveillance modules"
					}, {
						"subactivity_acronym" : "CREATEALG",
						"subactivity_id" : 92,
						"subactivity_name" : "Create up to 5 complex and 3 modular algorithms"
					}
				]
			}
		],
		"id" : "12"
	}, {
		"activities" : [{
				"activity_acronym" : "BDEF",
				"activity_id" : 40,
				"activity_name" : "Complete the birth defects study",
				"subactivities" : []
			}, {
				"activity_acronym" : "TPILOT",
				"activity_id" : 41,
				"activity_name" : "Pilot of Self Controlled Tree-Temporal Scan Analysis for Gardasil Vaccine",
				"subactivities" : []
			}
		],
		"id" : "13"
	}, {
		"activities" : [{
				"activity_acronym" : "EXPERT",
				"activity_id" : 42,
				"activity_name" : "Provision of Expert Input on Statistical, Epidemiologic, and Clinical Issues",
				"subactivities" : [{
						"subactivity_acronym" : "TBD1",
						"subactivity_id" : 100,
						"subactivity_name" : ""
					}
				]
			}, {
				"activity_acronym" : "TBD1",
				"activity_id" : 43,
				"activity_name" : "Use Current Modular Programs, Tools and Modules Developed for Routine Prospective Safety Surveillance, and De Novo Programming to Address CDER Drug Safety Issues",
				"subactivities" : [{
						"subactivity_acronym" : "TBD1",
						"subactivity_id" : 101,
						"subactivity_name" : ""
					}
				]
			}
		],
		"id" : "14"
	}, {
		"activities" : [{
				"activity_acronym" : "ALERT",
				"activity_id" : 44,
				"activity_name" : "Infrastructure for evaluating Data Mining Alerts",
				"subactivities" : []
			}, {
				"activity_acronym" : "HPV",
				"activity_id" : 45,
				"activity_name" : "Extension of the Protocol based safety assessment for HPV vaccine",
				"subactivities" : []
			}, {
				"activity_acronym" : "QUNC",
				"activity_id" : 46,
				"activity_name" : "Quantifying uncertainty in protocol based assessments",
				"subactivities" : []
			}, {
				"activity_acronym" : "TPOW",
				"activity_id" : 47,
				"activity_name" : "Decision analysis model to evaluate alternative approaches to safety assessments",
				"subactivities" : []
			}
		],
		"id" : "15"
	}, {
		"activities" : [{
				"activity_acronym" : "CAP",
				"activity_id" : 48,
				"activity_name" : "Establish Capacity for Timely Response to MSOC Queries and Participation in Data Partner Activities",
				"subactivities" : [{
						"subactivity_acronym" : "LABCHAR",
						"subactivity_id" : 107,
						"subactivity_name" : "Lab Characterization"
					}, {
						"subactivity_acronym" : "RPT",
						"subactivity_id" : 108,
						"subactivity_name" : "Reports"
					}, {
						"subactivity_acronym" : "ETLQ",
						"subactivity_id" : 106,
						"subactivity_name" : "ETL Questionnaire"
					}
				]
			}, {
				"activity_acronym" : "PREP",
				"activity_id" : 49,
				"activity_name" : "Prepare Summary Tables to Support the MS Distributed Query Tool and Test Modular Programs and Query Tool Revisions",
				"subactivities" : []
			}, {
				"activity_acronym" : "UPD",
				"activity_id" : 50,
				"activity_name" : "Update the MSDD",
				"subactivities" : []
			}
		],
		"id" : "16"
	}, {
		"activities" : [{
				"activity_acronym" : "FS4",
				"activity_id" : 51,
				"activity_name" : "Assessment of Febrile Seizues after Influenza for 4 seasons",
				"subactivities" : []
			}, {
				"activity_acronym" : "HPV9SAB",
				"activity_id" : 52,
				"activity_name" : "Evaluation of Spontaneous Abortion after Gardasil Vaccination",
				"subactivities" : []
			}, {
				"activity_acronym" : "MBGSS",
				"activity_id" : 53,
				"activity_name" : "General Safety Study for Meningococcal Vaccines",
				"subactivities" : []
			}, {
				"activity_acronym" : "ODON",
				"activity_id" : 54,
				"activity_name" : "Assessing the safety of human cells and tissues",
				"subactivities" : []
			}, {
				"activity_acronym" : "QUB1",
				"activity_id" : 55,
				"activity_name" : "Quantitative Bias Analysis Methodology Development",
				"subactivities" : []
			}
		],
		"id" : "18"
	}, {
		"activities" : [{
				"activity_acronym" : "ASSESS",
				"activity_id" : 56,
				"activity_name" : "Protocol Based Assessment for a Blood Component or Blood?Derived Product",
				"subactivities" : [{
						"subactivity_acronym" : "TBD",
						"subactivity_id" : 117,
						"subactivity_name" : ""
					}
				]
			}
		],
		"id" : "BS01T"
	}, {
		"activities" : [{
				"activity_acronym" : "FA",
				"activity_id" : 100005,
				"activity_name" : "fake",
				"subactivities" : [{
						"subactivity_acronym" : "sfa",
						"subactivity_id" : 100013,
						"subactivity_name" : "subfake"
					}
				]
			}
		],
		"id" : "fake"
	}
]
